Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents

被引：0
|
作者：
Matthew Alcusky
Jennifer Tjia
David D. McManus
Anne L. Hume
Marc Fisher
Kate L. Lapane
机构：
[1] University of Massachusetts Medical School,Department of Population and Quantitative Health Sciences
[2] University of Massachusetts Medical School,Department of Medicine, Division of Cardiovascular Medicine
[3] University of Rhode Island,Department of Pharmacy Practice, College of Pharmacy
[4] Harvard Medical School,Department of Neurology, Beth Israel Deaconess Medical Center
来源：
Journal of General Internal Medicine | 2020年 / 35卷
关键词：
comparative effectiveness; anticoagulants; atrial fibrillation; nursing homes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2329 / 2337
页数：8
相关论文
共 50 条
  • [31] Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia
    Fang, Chen-Wen
    Hsieh, Cheng-Yang
    Yang, Hsin-Yi
    Tsai, Ching-Fang
    Sung, Sheng-Feng
    EUROPEAN STROKE JOURNAL, 2024,
  • [32] THE ROLE OF CHRONIC ANTI-COAGULATION WITH WARFARIN AND DIRECT-ACTING ORAL ANTICOAGULANTS ON HEPATIC DECOMPENSATION AND MORTALITY IN A LARGE NATIONAL COHORT.
    Serper, Marina
    Taddei, Tamar H.
    Cohen, Jordana
    Weinberg, Ethan M.
    Kaplan, David E.
    HEPATOLOGY, 2019, 70 : 97A - 98A
  • [33] Direct Comparison of the Effectiveness and Safety Among Direct Oral Anticoagulants and Warfarin in Japanese Patients: Nationwide Cohort Study in Japan
    Katayama, Saki
    Aoki, Yuka
    Akita, Ayu
    Satake, Rino
    Tohkin, Masahiro
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 1023 - 1033
  • [34] Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors
    Carney, Brian J.
    Uhlmann, Erik J.
    Puligandla, Maneka
    Mantia, Charlene
    Weber, Griffin M.
    Neuberg, Donna S.
    Zwicker, Jeffrey I.
    BLOOD, 2018, 132
  • [35] Risk factors associated with post-extraction bleeding in patients on warfarin or direct-acting oral anticoagulants: a retrospective cohort study
    Iwata, Eiji
    Tachibana, Akira
    Kusumoto, Junya
    Hasegawa, Takumi
    Kadoya, Ryo
    Enomoto, Yui
    Takata, Naoki
    Akashi, Masaya
    ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG, 2022, 26 (04): : 641 - 648
  • [36] Risk factors associated with post-extraction bleeding in patients on warfarin or direct-acting oral anticoagulants: a retrospective cohort study
    Eiji Iwata
    Akira Tachibana
    Junya Kusumoto
    Takumi Hasegawa
    Ryo Kadoya
    Yui Enomoto
    Naoki Takata
    Masaya Akashi
    Oral and Maxillofacial Surgery, 2022, 26 : 641 - 648
  • [37] A SINGLE CENTER RETROSPECTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DIRECT-ACTING ORAL ANTICOAGULANTS VS WARFARIN IN LEFT VENTRICULAR THROMBUS
    Khan, Muhammad Aslam
    Lamichhane, Bikal
    Shabih, Sohaib
    Bhattarai, Shraddha
    Rahman, Hammad
    Aafreen, Asna
    Bhatta, Ghanshyam
    Anwar, Ayesha
    Hasan, Khwaja
    Gondal, Amlish
    Sharma, Saurabh
    CHEST, 2024, 166 (04) : 858A - 859A
  • [38] Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study
    Pratt, Nicole L.
    Ramsay, Emmae
    Ellett, Lisa M. Kalisch
    Duszynski, Katherine
    Shakib, Sepehr
    Kerr, Mhairi
    Caughey, Gillian
    Roughead, Elizabeth Ellen
    BMJ OPEN, 2019, 9 (05):
  • [39] Effect of Direct-acting Oral Anticoagulants and Warfarin on Hospital Outcomes in Upper Gastrointestinal Bleeding
    Solakoglu, Tevfik
    Koseoglu, Huseyin
    Kucukmetin, Nurten Turkel
    Akar, Mustafa
    Mete, Rafet
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (10): : 1266 - 1271
  • [40] Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism
    Coons, James C.
    Albert, Lauren
    Bejjani, Andrea
    Iasella, Carlo J.
    PHARMACOTHERAPY, 2020, 40 (03): : 204 - 210
12345